Use of Obesity Medications in the Era of GLP-1 Agonists: An Expert Panel Discussion
Perm J
.
2024 Dec 16;28(4):7-19.
doi: 10.7812/TPP/24.176.
Epub 2024 Dec 10.
Authors
Jamy Ard
1
,
Lydia Alexander
2
,
Daniel Bessesen
3
,
Karlijn Burridge
4
,
Sean Hasan Hashmi
5
Affiliations
1
Epidemiology and Prevention, Wake Forest University School of Medicine , Winston-Salem, NC, USA.
2
Enara Health , San Mateo, CA, USA.
3
Division of Endocrinology, Metabolism, and Diabetes, University of Colorado , Denver, CO, USA.
4
Ascension Weight Loss Solutions , Westmont, IL, USA.
5
Southern California Permanente Medical Group, Lifestyle and Obesity Medicine , Porter Ranch, CA, USA.
PMID:
39654407
PMCID:
PMC11648321
DOI:
10.7812/TPP/24.176
No abstract available